-
Loading metrics
Open Access
Peer-reviewed
Research Article
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial
-
Tuija Väänänen,
Roles Conceptualization, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
⨯ -
Katriina Vuolteenaho ,
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: katriina.vuolteenaho@uta.fi
Affiliation The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
⨯ -
Hannu Kautiainen,
Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Visualization, Writing – review & editing
Affiliations Department of General Practice, University of Helsinki, Helsinki, Finland, Unit of Primary Health Care, Helsinki University Hospital, Helsinki, Finland, Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, MedCare Ltd, Äänekoski, Finland
⨯ -
Riina Nieminen,
Roles Conceptualization, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing
Affiliation The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
⨯ -
Timo Möttönen,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Rheumatology, University of Turku and Turku University Hospital, Turku, Finland
⨯ -
Pekka Hannonen,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Medicine, Jyväskylä Central Hospital, Jyväskylä, Finland
⨯ -
Markku Korpela,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland
⨯ -
Markku J. Kauppi,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliations Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland
⨯ -
Kari Laiho,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland
⨯ -
Oili Kaipiainen-Seppänen,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Medicine, Kuopio University Hospital, Kuopio, Finland
⨯ -
Riitta Luosujärvi,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
⨯ -
Tea Uusitalo,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Medicine, Hämeenlinna Central Hospital, Hämeenlinna, Finland
⨯ -
Toini Uutela,
Roles Investigation, Project administration, Resources, Writing – review & editing
Affiliation Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland
⨯ -
Marjatta Leirisalo-Repo,
Roles Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing – review & editing
Affiliation Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
⨯ -
Eeva Moilanen,
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation The Immunopharmacology Research Group, Faculty of Medicine and Life Sciences, University of Tampere and Tampere University Hospital, Tampere, Finland
⨯ - [ ... ],
-
on behalf of the NEO-RACo Study Group
¶All the authors named in the author list are members of the NEO-RACo Study Group. Other members of the NEO-RACo Study Group are provided in the Acknowledgments.
⨯ - [ view all ]
- [ view less ]
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial
- Tuija Väänänen,
- Katriina Vuolteenaho,
- Hannu Kautiainen,
- Riina Nieminen,
- Timo Möttönen,
- Pekka Hannonen,
- Markku Korpela,
- Markku J. Kauppi,
- Kari Laiho,
- Oili Kaipiainen-Seppänen
- Published: August 25, 2017
- https://doi.org/10.1371/journal.pone.0183294